» Articles » PMID: 15502877

Tissue Factor and Cancer Metastasis: the Role of Intracellular and Extracellular Signaling Pathways

Overview
Journal Mol Med
Publisher Biomed Central
Date 2004 Oct 27
PMID 15502877
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue factor (TF) initiates the coagulation cascade but also plays a role in cancer and metastasis. This transmembrane protein is frequently upregulated on tumor cells and cells that show metastatic behavior. Furthermore, it is a significant risk factor for hepatic metastasis in patients suffering from colon cancer. Recently, it has been shown that TF, together with its natural ligand factor VIIa, induces intracellular changes, such as signal transduction cascades, gene transcription, and protein synthesis. Moreover, TF:factor VIIa interaction leads to survival of cells that have been stimulated to undergo apoptosis. Together with TF-dependent processes such as angiogenesis, these intracellular phenomena form a plausible explanation for the influence of TF on metastasis. In this review, we will discuss these phenomena in more detail and hypothesize on their role in TF-driven metastasis.

Citing Articles

The Role of Tissue Factor In Signaling Pathways of Pathological Conditions and Angiogenesis.

Heidari Z, Naeimzadeh Y, Fallahi J, Savardashtaki A, Razban V, Khajeh S Curr Mol Med. 2023; 24(9):1135-1151.

PMID: 37817529 DOI: 10.2174/0115665240258746230919165935.


Exposure-safety and exposure-efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumors.

Passey C, Voellinger J, Gibiansky L, Gunawan R, Nicacio L, Soumaoro I CPT Pharmacometrics Syst Pharmacol. 2023; 12(9):1262-1273.

PMID: 37496366 PMC: 10508544. DOI: 10.1002/psp4.13007.


The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans.

Hassan N, Efing J, Kiesel L, Bendas G, Gotte M Cancers (Basel). 2023; 15(5).

PMID: 36900315 PMC: 10001432. DOI: 10.3390/cancers15051524.


Delineating the role of extracellular vesicles in cancer metastasis: A comprehensive review.

Majood M, Rawat S, Mohanty S Front Immunol. 2022; 13:966661.

PMID: 36059497 PMC: 9439583. DOI: 10.3389/fimmu.2022.966661.


Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study.

Yonemori K, Kuboki Y, Hasegawa K, Iwata T, Kato H, Takehara K Cancer Sci. 2022; 113(8):2788-2797.

PMID: 35633184 PMC: 9357646. DOI: 10.1111/cas.15443.


References
1.
Wilcox J, Smith K, Schwartz S, Gordon D . Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989; 86(8):2839-43. PMC: 287014. DOI: 10.1073/pnas.86.8.2839. View

2.
Bach R . Initiation of coagulation by tissue factor. CRC Crit Rev Biochem. 1988; 23(4):339-68. DOI: 10.3109/10409238809082548. View

3.
Fidler I . Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res. 1990; 50(19):6130-8. View

4.
Bazan J . Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A. 1990; 87(18):6934-8. PMC: 54656. DOI: 10.1073/pnas.87.18.6934. View

5.
Fleck R, Rao L, RAPAPORT S, Varki N . Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res. 1990; 59(2):421-37. DOI: 10.1016/0049-3848(90)90148-6. View